European Stocks Rise Most in a Month as AstraZeneca Gains
This article is for subscribers only.
European stocks advanced, with the Stoxx Europe 600 Index climbing the most in more than a month, as U.S. and U.K. markets reopened following a public holiday.
AstraZeneca Plc rose to its highest price since 2006 after the U.K.’s second-biggest drugmaker agreed to buy Omthera Pharmaceuticals Inc. for $323 million. Victrex Plc climbed to the highest price since its initial public offering in 1995. Aixtron SE jumped 7.8 percent after Natixis recommended buying the maker of equipment for the semiconductor industry.